As of Oct 12
| -0.07 / -0.14%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 63.00, with a high estimate of 71.00 and a low estimate of 50.00. The median estimate represents a +27.32% increase from the last price of 49.48.
The current consensus among 5 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.